$HCAT News

Canaccord Genuity Downgrades Health Catalyst to Hold, Lowers Price Target to $1.8

5 Must-Read Analyst Questions From Health Catalyst’s Q2 Earnings Call

Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript

Wells Fargo Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.5

Citigroup Maintains Neutral on Health Catalyst, Lowers Price Target to $2

HCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Health Catalyst, Inc. Q2 2026 Earnings Call Summary

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst Shares Tumble Overnight: What Investors Need to Know

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst (NASDAQ:HCAT) Exceeds Q2 CY2026 Expectations But Stock Drops 25.5%

Health Catalyst (NASDAQ:HCAT) Tumbles 24% on Weak Guidance Despite Q2 Earnings Beat

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results

Health Catalyst Sees FY2026 Sales $246.000M-$249.000M vs $260.780M Est

Health Catalyst Sees Q3 Sales $55.000M-$56.000M vs $62.159M Est

Health Catalyst Q2 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $70.487M Beat $69.059M Estimate